Form 4: Clorox COO Exercises Options, Sells Shares
Insider Transaction Report
Clorox EVP and COO Eric H. Reynolds exercised stock options and subsequently sold a portion of his common stock holdings.
Summary
- Eric H. Reynolds, Executive Vice President and Chief Operating Officer of Clorox Co (CLX), engaged in transactions involving the company's common stock.
- On September 4, 2025, Reynolds exercised stock options to acquire 15,210 shares of common stock at an exercise price of $111.6 per share.
- Immediately following the option exercise on September 4, 2025, Reynolds sold 15,041 shares of common stock.
- The shares were sold at a weighted average price of $123.7848 per share, with individual trades ranging from $123.731 to $123.84.
- These transactions were conducted under a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
- Following these reported transactions, Reynolds beneficially owns 54,221 shares of Clorox common stock.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions (option exercise and subsequent sale) conducted under a pre-arranged 10b5-1 plan. While an insider sale reduces direct ownership, the pre-scheduled nature mitigates negative sentiment. The executive realized a profit on the option exercise, which is a common part of executive compensation.
Positives
- The transactions were executed under a Rule 10b5-1(c) plan, suggesting pre-scheduled trading rather than a reaction to immediate market events.
- The sale price of $123.7848 per share is higher than the option exercise price of $111.6, indicating a profitable transaction for the insider.
Negatives
- An insider sale, even if pre-scheduled, reduces the executive's direct equity stake in the company, which can sometimes be perceived neutrally to slightly negatively by the market.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May view the insider sale as a routine event, especially given the pre-scheduled 10b5-1 plan, which reduces the likelihood of it being interpreted as a signal of negative company prospects. The executive retains a significant stake, maintaining alignment of interests.
- Employees/Management: These transactions are a standard component of executive compensation and personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 09/15/2016 | Date stock option became exercisable |
| 09/04/2025 | Date of stock option exercise and subsequent sale of common stock |
| 09/08/2025 | Date Form 4 was signed |
| 09/15/2025 | Expiration date of stock option |
Recommendation
holdThe filing details routine insider stock transactions, specifically an option exercise and subsequent sale, conducted under a pre-arranged 10b5-1 plan. These types of transactions are common for executives for liquidity and diversification purposes and do not typically signal a change in the company's fundamental outlook. Therefore, based solely on this Form 4, a 'hold' recommendation is appropriate as it provides no new material information to alter an existing investment thesis.
Keywords
Clorox, CLX, Insider Trading, Form 4, Stock Options, Equity Sales, Executive Compensation, Eric H. Reynolds, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.